22.626 articles found

Stem cells: a new paradigm in medical therapeutics.

Mankikar SD.

J Long Term Eff Med Implants · 2010-01-01

DOI: 10.1615/jlongtermeffmedimplants.v20.i3.50PMID: 21395520

Effects of chronic low dose rotenone treatment on human microglial cells.

Shaikh SB, Nicholson LF.

Mol Neurodegener · 2009-12-31

DOI: 10.1186/1750-1326-4-55PMID: 20042120

Successful intra-arterial chemotherapy for extramammary Paget's disease of the axilla in a patient with Parkinson's disease.

Damascelli B, Ticha V.

Cardiovasc Intervent Radiol · 2009-12-31

DOI: 10.1007/s00270-009-9786-1PMID: 20043224

BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME

HAHN HOH-GYU, NAM KEE-DAL, SHIN DONG-YUN, PARK CHAN-HO, CHO SUNG-WOO, KIM EUN-A, NAM GHIL-SOO, CHOI KYUNG-IL, SEO SEON-HEE, SHIN HEE-SUP, KIM DONG-JIN, PAE AE-NIM, CHUNG HYE-JIN, CHOO HYUN-AH, RHIM HYE-WHON, CHO YONG-SEO, ROH EUN-JOO, KEUM GYO-CHANG, CHOI KEE-HYUN, SHIN KYE-JUNG, CHEONG CHAN-SEONG, LEE JAE-KYUN, KANG YONG-KOO, KIM YOUNG-SOO, PARK WOONG-SEO, KIM KEY-SUN, CHUNG HE-SSON, SONG CHI-MAN, MIN SUN-JOON, KIM EUNICE EUN-KYEONG, LEE CHEOL-JU, KANG SOON-BANG.

· 2009-12-29

BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME

HAHN HOH-GYU, NAM KEE-DAL, SHIN DONG-YUN, PARK CHAN-HO, CHO SUNG-WOO, KIM EUN-A, NAM GHIL-SOO, CHOL KYUNG-IL, SEO SEON-HEE, SHIN HEE-SUP, KIM DONG-JIN, PAE AE-NIM, CHUNG HYE-JIN, CHOO HYUN-AH, RHIM HYE-WHON, CHO YONG-SEO, ROH EUN-JON, KEUM GYO-CHANG, CHOI KEE-HYUN, SHIN KYE-JUNG, CHEONG CHAN-SEONG, LEE JAE-KYUN, KANG YONG-KOO, KIM YOUNG-SOO, PARK WOONG-SEO, KIM KEY-SUN, CHUNG HE-SSON, SONG CHI-MAN, MIN SUN-JOON, KIM EUNLCE EUN-KYEONG, LEE CHEOL-JU, KANG SOON-BANG.

· 2009-12-29

Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.

Ouattara B, Grégoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T.

Neurobiol Aging · 2009-12-29

DOI: 10.1016/j.neurobiolaging.2009.07.014PMID: 20036444

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.

Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N.

Eur J Neurol · 2009-12-27

DOI: 10.1111/j.1468-1331.2009.02894.xPMID: 20050890

NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

NIESTROJ ANDRE J, HEISER ULRICH, SCHULZ INGO, RAHFELD JENS-ULRICH, BAER JOACHIM, DEMUTH HANS-ULRICH.

· 2009-12-23

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.

Cardoso S, Santos R, Correia S, Carvalho C, Zhu X, Lee HG, Casadesus G, Smith MA, Perry G, Moreira PI.

Pharmaceuticals (Basel) · 2009-12-23

DOI: 10.3390/ph2030250PMID: 27713238

Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine.

Broderick PA, Kolodny EH.

Pharmaceuticals (Basel) · 2009-12-22

DOI: 10.3390/ph2030236PMID: 27713237

USE OF CREATINE OR CREATINE ANALOGS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM

KADDURAH-DAOUK RIMA, BEAL M FLINT.

· 2009-12-18

Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.

Frank S.

BMC Neurol · 2009-12-18

DOI: 10.1186/1471-2377-9-62PMID: 20021666